Dannis Chang, PharmD
Director, Hematology Medical Information Team Lead, Genentech, Inc., United States
Dannis Chang, PharmD., is currently the Hematology Medical Communications Team Lead at Genentech Inc, where he leads the strategic development, planning, and delivery of scientific content, as well as enabling timely, relevant, personalized, accurate, balanced, and impactful communication of clinical information or scientific evidence to customers to enhance their experiences, support improved patient outcomes, and foster an ongoing connection aimed at maximizing medical progress. He received a doctorate of pharmacy degree from University of Southern California and a post-doctoral fellowship from Rutgers University.
Robert Tamburri, PharmD, MBA
Director, Medical Information and Knowledge Integration, Janssen Scientific Affairs, LLC, United States
Robert is Director of the Medical Information Communication Channels team at Janssen. In his current role, Rob is responsible for providing leadership in developing, shaping and implementing Medical Information Communication strategies as well as oversight of operations and related omnichannel modes of communications for the Medical Information Contact Center (internal and external) at Janssen. In addition to his 13 years of pharmaceutical industry experience, Rob also has 11 years of experience as a practicing pharmacist in various pharmacy practice settings. Rob earned his Bachelor of Science in Pharmacy from Temple University School of Pharmacy, his Doctor of Pharmacy degree from Shenandoah University, and his MBA from Drexel University.
Andrea Tuttle Meyers
Senior Vice President, Clinical Operations, Syneos Health, United States
Ms. Meyers is a Senior Vice President at Syneos Health. She has led clinical operations and medical writing teams for more than two decades in both CRO and sponsor organizations. Ms. Meyers has authored documents across all phases of clinical development for pharmaceutical products as well medical devices, including regulatory dossiers and submissions. In addition, she has also led regulatory and clinical development, leading two oncology products to NDA submission and subsequent approval. Prior to her career in clinical research, Ms. Meyers practiced neuropsychology. In 2020, Ms. Meyers was honored to be named a Healthcare Businesswomen's Association Luminary in recognition of her 25+ years of service in Clinical Research.
Sonja Wesley Hokett, PharmD, MS
Executive Director/Head of Medical Managed Care, BioXcel Therapeutics, United States
Residing in Branson, Missouri, Sonja holds PharmD degree from the University of Louisiana Monroe, Master of Science degree in Hospital Pharmacy Administration from the University of Houston, and Executive Master's degree Health Economics, Policy & Management from the London School of Economics. During her 19 years in the pharma industry, Sonja has held both Field and Headquarter pharma Medical Affairs positions at BioXcel Therapeutics, Jazz, Intercept, and Genentech. She currently manages a Medical Managed Care field team and oversees HEOR for BioXcel Therapeutics.
Darshan Kulkarni, JD, PharmD, MS
Principal Attorney, The Kulkarni Law Firm, United States
Dr. Kulkarni is Principal Attorney for the Kulkarni Law Firm which focuses on providing legal and regulatory solutions to pharmaceutical companies and their providers. He is a pharmacist & lawyer and advises clients on bringing their product to market, focusing on post IND thru commercialization and genericization.
Marie-Ange Noue, PhD
Senior Director, Head of Scientific Communications , EMD Serono, Canada
Marie-Ange Noue is a PhD chemist trained at Curie University in Paris and at the University of Houston. She started her career working as a research scientist in petrochemicals. She later found her niche upon joining EMD Serono in 2008, where she’s held a number of positions of increasing responsibility. In her current role as Senior Director, Head of US Scientific Communications, she provides strategic leadership and oversight for activities related to Medical Information, Medical Communication, Medical Training, and Medical Education for the US. Marie-Ange chairs the Board of Directors of the Canadian Medical information network, and serves as Vice President on the Executive Board of PhactMI.
Sonia Sandhu, PharmD
Senior Director, Medical Information, Gilead Sciences, Inc., United States
Sonia is a Senior Director of Global Medical Information at Gilead Sciences, where she oversees the Virology and Established Products portfolios. She is a leader in medical insights, heading up her department's first patient insights initiative, and presenting the findings at DIA and other patient engagement forums. Throughout her career, Sonia has acquired extensive knowledge in various therapeutic areas and has published articles on medical information. Sonia has been a member of DIA since 2019 and has actively participated in the organization, serving on the DIA planning committee for the past two years.
Elizabeth Brown, MS, PMP
Director, Oncology Medical Writing Lead, Merck & Co., Inc., United States
Elizabeth Brown is a Director and TA Lead of Oncology Medical Writing at Merck & Co, Inc. near Philadelphia, PA. She has led regulatory projects and initiatives in the pharmaceutical industry for 20+ years. First as a laboratory scientist, then as a clinical researcher, and currently as a medical writer. Elizabeth brings a project and people management focus to her role as a regulatory medical writer and department leader. With this focus, she has developed a passion for developing people, advising teams and providing strategic guidance how to deliver efficient, effective, and high-quality documents.
Diane Cleverley, PhD
Senior Regulatory Writer, Synchrogenix, United States
Dr. Cleverley has more than 20 years experience in the medical publication field, which she entered shortly after earning her PhD in Microbiology and Molecular Genetics as a joint degree from Rutgers and UMDNJ. During that time, she proposed the “glycine hinge” theory. She has contributed editorial support for publications for prestigious higher tier journals such as NEJM and JCO. Dr. Cleverley has also written award-winning patient literature, clinical trial materials, and healthcare provider education. She currently is lending her writing talents to the regulatory field. She developed a patient advocacy tool for making diagnosis more effective. Dr. Cleverley has been an active team member of AMWA, ISMPP, and MAPS, and holds a CMPP.
Lisa DeTora, PhD, MS
Associate Professor, Director of STEM Writing, Hofstra University, United States
Lisa is an assistant professor of Writing Studies at Hofstra University, where she teaches a wide range of courses including scientific writing, health communication, medical humanities, and narrative medicine. Her research interests include vaccination policy, medical humanities, publication ethics, regulatory writing, and theories of the body. Lisa is the lead author of Good Publication Practice Guidelines for Company-Sponsored Biomedical Research: 2022 Update and the editor of Regulatory Writing an Overview.
Elizabeth Froom, PharmD
Senior Director, Medical Writing and Healthcare Communications, Evidera, United States
Elizabeth C. Froom, PharmD, is a Senior Director in the Medical Writing and Healthcare Communications team at Evidera. In this role, she provides strategic direction and oversight to ensure delivery of quality medical information deliverables. Elizabeth has more than 24 years of medical information and medical writing experience. She has experience authoring and reviewing standard and global response letters, custom response letters, frequently asked questions, and Academy of Managed Care Pharmacy (AMCP) dossiers. Her educational background includes a BS in pharmacy and a PharmD from the University of South Carolina College of Pharmacy.
Paul Minne, PharmD, RPh
Senior Director, MSL Team, Neurocrine Biosciences, United States
Paul Minne has over 20 years of experience in medical affairs within the biopharmaceutical industry. During his career, he has had substantial experience with all phases of drug development and support, multiple new product launches, and management of MSL Teams. He has earned a BS from Drake University and a Doctor of Pharmacy from the University of Colorado Health Sciences Center, is a licensed pharmacist and preceptor with the State of Colorado, and is an adjunct professor at the University of Colorado Skaggs School of Pharmacy. Paul resides in Parker, Colorado.
Kay Uttech, PharmD, MA, RPh
VP, Strategic Initiatives, Indegene, United States
Kay Uttech is VP for Strategic Initiatives at Indegene working with companies to build and optimize medical affairs services. She has more than 20 years’ experience in the pharmaceutical and medical device industry. Kay has held roles in Medical Affairs as a MSL and leading MSL teams in North America. Additionally, she has also held other responsiiblities in Medical Communication and Information; development of global scientific knowledge management systems; grants for ISS and medical education; and promotional review. Her current work is focused on leveraging technology to drive efficiency that optimizes the medical and scientiifc expertise of Medical Affairs teams.
J. Lynn Bass, PharmD, RPh
Senior Director, Medical Science Liaisons, BridgeBio, United States
With 24+ years of experience in Medical Affairs roles across the pharmaceutical industry, Lynn is currently the Senior Director, Head of Medical Sciences at Medexus Pharma. Her industry career has spanned many therapeutic areas and she has authored/ co-authored several MSL surveys. Lynn is the elected Chair of the Medical Science Liaison Community and serves on the DIA's North America Regional Advisory Council. She is a regular, invited panelist at MSL and Medical Affairs events. Lynn holds B.S. degrees in Biology and Medical Technology. She received her B.S. in Pharmacy from the Medical College of Virginia and her Doctor of Pharmacy degree from the University of South Carolina.
Tamei Elliott, MS
Associate Director, Scientific Programs, DIA, United States
Tamei Elliott is the Senior Manager of Scientific Programs for the Americas Region at DIA. She is responsible for identifying and prioritizing content areas and topics of importance to DIA constituents, assessing the implications of important regulatory and health policy changes, and incorporating appropriate content into the development and advancement of content for DIA conferences and courses. Prior to DIA, Tamei worked as a Regulatory Affairs Specialist where she maintained a portfolio of INDs and protocols for clients and was responsible for the preparation, tracking, and submission of regulatory documents to regulatory health authorities. She has her master's degree in biotechnology and bachelor's degree in nutritional science.
Exhibitor Sponsored Events
, United States
Stacey Follman, PharmD, RPh
Director, Global Content Management, Pfizer, United States
Dr. Stacey Follman has spent her 26-year pharmacy career at Pfizer including 15 years in the World-Wide Safety and Regulatory department in Safety Evaluation and Reporting and 11 years in Medical information. Formerly the Director, Student Affairs and currently Director, Global Content Management in Pfizer’s Global Medical Information Department . Dr. Follman has experience overseeing scholarly activities associated with approximately 10 APPE Pharmacy rotational students annually, the Student Summer Worker program and the recruitment and preceptorship of post-doctoral Fellows. In addition, she maintains internal/external partnerships, leading student/fellow initiatives with multiple scientific institutions.
Sarica Klein, PharmD
Field Director, US Medical, Neuropsychiatry - West, Biogen, United States
Dipam Doshi, PharmD
Principal Medical Science Liaison, 0140, United States
Dipam Doshi graduated with his PharmD from University of the Pacific in 2010. After graduating he completed a one year fellowship at Daiichi Sankyo within the Rutgers Pharmaceutical Industry Fellowship program. From 2011-2015, Dipam Doshi has been a Medical Science Liaison with Daiichi Sankyo. From May 2015, Dipam has been a Sr. MSL at ZS Pharma covering Southern California. More recently, Dipam has been a Principal Medical Science Liaison at SpringWorks Therapeutics. As one of the first MSLs at ZS Pharma and SpringWorks Therapeutics, he enjoys strategically building out tools and capabilities for the MSL team.
Associate Director, Digital Solutions, DIA, United States
Kari Loeser, JD
Vice President, Chief Compliance Officer, Cytokinetics, United States
Kari is Vice President and Chief Compliance Officer for Cytokinetics, Inc., where she provides executive management, direction, and oversight for all aspects of the compliance program, policies, monitoring, training, privacy, and brand-legal advisory. Previously, Kari was the US Healthcare Compliance and Privacy Officer and Senior Corporate Counsel at Vifor Pharma, Inc., and a Senior Director/Senior Compliance Counsel at Jazz Pharmaceuticals. She has extensive experience in providing legal and compliance advice on sales, marketing, promotional and medical materials review, Medical Affairs, managed care, commercial compliance, as well as U.S. Sunshine / aggregate spend and compliance operations.
Ellen Whipple, PharmD
Owner/Principal Writer, EW Associates, LLC, United States
Ellen is the co-owner of Scientific Content Solutions, LLC and the sole proprietor of EW Associates, LLC. She was previously a director of medical communications with an agency. Ellen has experience with medical information-related documents (e.g., standard letters, FAQs, dossiers, escalated inquiries), continuing education articles, primary author publications, promotional review, payer materials, and advisory board meeting reports. As a member of AMCP Format Executive Committee, Ellen contributed to AMCP Format 4.1. She serves as a Clinical Assistant Professor at the University of Georgia College of Pharmacy. Since 2000, Ellen has been a Medical Advisor for the MS Foundation.
Michael J DeLuca, PharmD, MBA, MS, RPh
Senior Vice President of Medical Affairs, EVERSANA, United States
Michael has 20 years of healthcare and pharmaceutical industry experience in multiple leadership roles at several pharmaceutical companies. He has extensive experience in medical information, medical communications and in supporting medical review of promotional / non-promotional materials. Throughout his career, Michael has supported multiple product launches across various therapeutic areas, including rare diseases, and he has led MI activities from both a US and global perspective. Michael has led and grown established MI teams and has built a MI department and services from the ground up. Michael's educational background includes Doctor of Pharmacy, Master of Business Administration, and Master of Science in Regulatory Affairs degrees.
Komal Bawa, PharmD
Senior Evidence Synthesis Scientist, US Medical Affairs, Genentech, United States
Dr. Komal Bawa has taken on various roles in Medical Affairs at Genentech since joining in 2014. She currently focuses on evidence synthesis in the health economics and outcomes research organization, leading the dossier strategy for the portfolio. Similar to many other pharmacists, Komal started in medical communications before venturing out into other roles to broaden her experience. Prior to joining industry, she worked as an emergency medicine clinical pharmacist at UCSF and Brigham and Women's Hospital. Komal lives in San Francisco where she has been "getting to know" her family a little too well these days, but enjoys cooking with the kids, long walks with her mom, and can't wait to travel again.
Director, Regulatory Services Management, Certara , United States
David Meats is an Associate Director of global submissions and regulatory services management at Certara Synchrogenix. He has been a medical writer for approximately 20 years working in oncology, immuno-oncology, endocrinology, musculoskeletal, cardiac, hepatic, renal, and infectious disease therapeutic areas on nearly every available clinical document type. He specializes in leading and writing FDA and EMA regulatory submissions and aggregate safety reports. David is the co-chair of the DIA MASC 2022 conference, and has been a member of DIA for 7 years.
Gary Messplay, JD
Partner, King & Spalding, LLP, United States
Gary Messplay is a Partner in the Washington, D.C., office of King & Spalding. He represents life sciences clients before the Food and Drug Administration (FDA), Drug Enforcement Agency (DEA), and other federal and state agencies. Mr. Messplay's practice includes regulatory and administrative law matters, clinical trials, criminal and civil enforcement matters, healthcare compliance, internal investigations, litigation, liability counseling, and transactional work related to pharmaceutical products. He has written extensively about pharmaceutical compliance issues and is a frequent speaker on regulatory and compliance matters. He is a member of the Food and Drug Law Institute, where he serves on FDLI’s Editorial Advisory Board.
Kajal Patel, PharmD
Executive Medical Reviewer, Takeda Pharmaceuticals, Inc., United States
Kajal is a seasoned pharmacist with 15+ years of experience in pharmaceutical and managed care sectors. She has in-depth knowledge and experience in business planning and execution of clinical strategy. Kajal serves as the lead medical reviewer for one of Takeda’s top products. She is skilled at extensive evaluation and providing strategic scientific consults on promotional patient-facing, HCP-facing, and payor-facing materials. Her diverse background ranges from launching branded social media platforms (Twitter, Facebook and YouTube), disease awareness materials, DTC TV ads, implementing CFL guidance in promotion and HCEI guardrails in payor materials, as well as implementing OPDP advisory comments.
Vice President Global Head of RMSC GEMI , Bayer, Australia
Life Science Strategic Advisor, SAS Institute Inc., United States
Matt Becker is an Advisory Industry Consultant with the SAS Global Hosting and U.S. Professional Services division. Matt’s more than 30 years of life science experience includes over 9 years with SAS concentrating on next generation clinical trials, data management, analysis, advanced analytics and deployment options in Life Science. As a leader for developing technology solutions to life science initiatives, Becker addresses the challenges that life science companies are having around the analytics lifecycle. The challenges result from new infrastructures that provide more data points than ever before, content management, compliance, collaboration and analytics.
Christy Cheung, PharmD, RPh
Lead, Digital Innovation & Transformation, Sanofi, Canada
Christy is a Digital Innovation & Transformation Lead at Sanofi and Co-founder of the AI Collective. She received her PharmD from the University of British Columbia, completed a Medical Director Fellowship at Sanofi, before taking on an MSL role, and more recently, making the transition from Medical to Digital. In her current role, she aspires to improve digital foundational literacy across internal stakeholders and to empower them to adopt a digital-first mindset in delivering innovative solutions to patients, healthcare professionals, and the broader healthcare system. Christy has been invited to speak at conferences such as DHX Virtual and ASHP. She also acts as a guest lecturer on the topics of digital health and AI.
Kent Christopherson, PhD
Executive Director & Head, Global Medical Affairs, Orchard Therapeutics, United States
Kent is Executive Director and Head, Global Medical Affairs at Orchard Therapeutics, a biotech company dedicated to unlocking the curative potential of hematopoietic stem cell – gene therapy for the benefit of individuals, families, and society. He is an accomplished medical affairs leader with >20 years of relevant clinical and scientific experience as well as multiple successful product launches within rare and ultra-rare diseases. In his current role, he brings substantial real-world experience to bear on the ever-evolving therapeutic landscape of gene therapy for the treatment of severe genetic diseases.
Purvi Dunn, MEd, MPA, PMP
Director, Capability Building Leadership Excellence, EMD Serono, United States
As the Director of Leadership Excellence, Purvi builds leadership capability within medical and commercial teams at EMD Serono, a critical investment in enhancing current and future leaders’ skills, abilities and confidence. Purvi brings 20+ years’ experience, most recently 7 years as a Senior Executive Consultant at the FDA, helping the agency develop their leadership development strategy and approach. As an ICF-certified coach, Purvi has worked with leaders at all levels, helping them gain important insights and empowering them to operationalize who they want to be as leaders. Purvi holds a BS in Health Science from the Univ. of Texas HSC, a MEd in Public Health Ed from Univ. of Houston, and a MPA from George Mason Univ.
Julia Forjanic-Klapproth, PhD
Senior Partner/President, Trilogy Writing & Consulting, Germany
After receiving her PhD in Developmental Neurobiology, Julia became a medical writer in 1997. In 2002, she co-founded Trilogy Writing & Consulting, a company specialized in medical writing of regulatory documentation. As Senior Partner and CEO, she continues to bring her enthusiasm and experience to client projects. She has twice been President of the European Medical Writers Association (EMWA), is an experienced trainer of medical writers, and runs workshops for EMWA, AMWA, DIA, and pharma companies around the world.
Matthew Gitlin, PharmD
Managing Director, BluePath Solutions, United States
Dr. Matthew Gitlin, is Founder and Managing Director of BluePath Solutions, a health services research consulting firm started in 2013 with a focus on population decision makers. He spent nearly a decade at a large biotechnology company working in global and European regional offices across market access related functions, supporting research and commercial activities. Matthew holds a Doctor of Pharmacy from the University of California, San Francisco (UCSF) and Bachelor of Science in Chemistry and Biochemistry from University of California, Santa Barbara. He has authored over 75 publications and is an Assistant Professor for the School of Pharmacy at UCSF.
Sarah Jarvis, MBA
Global Medical Affairs Lead, ZS, United States
Sarah Jarvis leads our Global Medical Affairs consulting space at ZS. Based now in San Francisco, California, Sarah has worked in the lifesciences industry for over 25 years and has focused exclusively on working with medical affairs clients for the past 15 years at ZS. ZS has worked with more than 100 companies' Medical Affairs organizations. Sarah also previously worked at Genentech in a variety of different roles on products that spanned therapy areas and phases of the lifecycle. With COVID acting as an accelerator on the medical function, ZS is partnering with clients to support the growth and change needed to meet global demands - in the field and in headquarters - through strategy, advanced analytics, and operations projects.
John Jones, MBA
Technology Director, PhactMI, United States
John Jones is an experienced IT Strategist focused on developing innovative technology solutions for unmet business needs in Life Sciences. John is currently the Founder and CEO of Entitech Solutions, a Life Sciences focused IT Software and Consulting firm. Prior to starting his company, John led Quintiles’ IT Consulting Division from 2010 – 2015 focusing on IT Advisory and Implementation services in Life Sciences. John has more than 20 years experience in developing and delivering IT Solutions for various companies, and has extensive experience in the clinical, regulatory, and commercial areas.
President & Executive Director, Hope In Pain, Inc., United States
Shoshana Lipson is a patient advocate, speaker, and writer. She has a passion to encourage, support, educate and inspire people living with migraine & chronic pain disorders, to find purpose and value in the midst of illness, and not give up hope. Shoshana leads an online community of over 20,000 members through Migraine Meanderings and Hope for Migraine, and in 2021 launched a new initiative called, Empowering Patient Voices. Shoshana collaborates with various advocacy organizations and pharmaceutical companies, is a contributing writer for Migraine.com, and speaks regularly on the topic of patient centricity. She is the President of Hope in Pain, Inc. and the Executive Director of Migraine Meanderings.
Inspirational Leadership Speaker & Author, Miracle Minnoy Motivation LLC, United States
Monica Saleh, PharmD
Field Medical Scientific Associate Director, Rare Blood Disorders, Sanofi, United States
Director, Product Management , Certara, United States
Trevor Standish is a Product Director with over ten years of experience in creating and implementing innovative software products across multiple industries, including pharmaceuticals, finance, and marketing. He is a customer-focused team leader with expertise in various areas such as product SDLC management, UI/UX design, AI/ML systems, and innovation. Trevor has extensive experience in managing software development life cycles, defining global product strategy and roadmaps, and leading teams in the transition to Agile methodologies. He has presented at various industry conferences, assisted global sales teams, and presented at executive roundtables. He has held positions at Certara, Concentric, Synchrogenix, and Fifth Third Bank.
Iris Tam, PharmD
Vice President and Head, Medical Affairs and HEOR , Coeus Consulting Group, United States
Iris Tam, PharmD, FAMCP, is Vice President & Head of Medical Affairs and HEOR at Coeus Consulting Group with over 30 years of experience in health care, including hospital pharmacy, managed care pharmacy, and the biopharmaceutical industry. In previous industry roles, she led Medical Affairs strategies and tactics that support market access, product value, and patient access, including accountabilities for medical communications, HEOR, AMCP dossiers, compendia submissions, guideline bodies engagement, and payer communications. From 2008 to 2021, Iris served on the AMCP Format Executive Committee which oversees the AMCP Format for Formulary Submissions for dossier development, including serving as the Chair for 3 years.
Brenda Taylor, MS
Director, Global Submissions, Synchrogenix, a Certara Company, United States
Brenda Taylor is a Director, Global Submissions at Synchrogenix, a Certara company and has over 20 years of experience in the biotechnology and pharmaceutical industry. She has led global writing teams and completed numerous Investigational New Drug and marketing authorization submissions to global regulatory agencies. With experience in writing virtually all submission documents, she brings writing and leadership abilities to submissions of any size. Brenda’s research background in microbiology and immunology includes design and performance of nonclinical studies. Her therapeutic areas of expertise include oncology, cardiovascular, and anti-infective agents, spanning both small molecule drugs and biologics.
Esther O Wojuade, PharmD
Director, Medical Information, Gilead Sciences, Inc., United States
Esther Wojuade is currently the Director of Global Medical Information at Gilead Sciences, where she oversees a team supporting the liver, inflammation and established product franchises. Her current responsibilities include leading a team in providing both global medical information support along with medical review committee & promotional review committee support. She has over 17 years of industry experience primarily in medical affairs across multiple therapeutic areas and has held various positions with increasing responsibilities. She received a B.S. in Chemistry from the University of Missouri-Columbia and her Doctor of Pharmacy from the University of Missouri- Kansas City.
Donna Booth, PharmD
Head, Field Medical Accounts-East, US Medical Affairs, GlaxoSmithKline, United States
Donna V. Booth, B.S, PharmD. is the Head of Field Medical Accounts (East) at GlaxoSmithKline. She has extensive experience across Medical Affairs in various leadership and strategy roles including Medical Information, HEOR and Field Medical. She currently leads a team of field liaisons focused on medical engagements related to clinical, economic and humanistic topics with Population Based Decision Makers at Payers and Health Systems. Donna received her Bachelor of Pharmacy from University of Georgia & her Doctor of Pharmacy from Medical University of South Carolina. Before joining industry, Donna was a clinical pharmacist with faculty appointments at local colleges of pharmacy.
Laura Sheppard, MA, MBA
Vice President, Regulatory Writing and Scientific Publications , Certara , United States
A skilled leader and communications professional with a record of outstanding achievement and rapid advancement into more progressively challenging positions.
Lisa Ambrosini Vadola, PhD, MA
Manager, Medical Writing, Whitsell Innovations, Inc., United States
Lisa Ambrosini Vadola is currently a Manager of Medical Writing at Whitsell Innovations, Inc, where she leads a team of medical writers and supports clients in the pharmaceutical and biotechnology industries with the preparation of clinical regulatory documents, including submissions to global regulatory agencies. In addition, Lisa provides consultation and training in regulatory medical writing. Before joining Whitsell Innovations, Inc., Lisa earned a PhD in Chemistry from Columbia University and completed postdoctoral training in the Laboratory of Chemical Biology and Microbial Pathogenesis at the Rockefeller University.
Mahek Chhatrapati, MBA
Chief Executive Officer, DocNexus, United States
Mahek Chhatrapati is the CEO of DocNexus, a healthtech company that is reinventing the global medical affairs ecosystem with search via AI-powered knowledge graphs. DocNexus is delivering insights from millions of scientific publications, clinical trials, claims, and news that would normally take days within seconds and making connecting with HCPs across the ecosystem a seamless process. Mahek is an experienced executive that has expertise delivering value to customers through innovative products at Amazon & AWS, where he helped large enterprise customers develop and scale their data lakes. Mahek holds his Masters in Business Administration from Duke University and his Bachelors of Science from The University of Texas.
Executive Director of Medical Communications, PPD, United States
Anna Eisenberg, MBA
Director, Life Sciences Business Development, Morningside, a Questel Company, United States
With over a quarter of a century devoted to localization industry, Anna is currently a leading member of the life sciences team in Morningside, a Questel company. Using a consultative approach, she advises her clients in pharma, biotech, medical devices, and healthcare, and on all aspects of localization for their regulatory, clinical and marketing needs. Combining her MBA in International Business, industry experience and knowledge of localization technology, Anna utilizes a strategic approach to mitigate global challenges and set-up processes tailored to the specific multi-language needs and requirements of life sciences companies.
Director, Account Management, Conduent, United States
Evelyn R. Hermes-DeSantis, PharmD
Director, Research and Publications, phactMI, United States
Evelyn R. Hermes-DeSantis, PharmD, BCPS, is the Director for Research and Publications for phactMI and Professor Emerita at the Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey. She is dedicated to advancing and elevating the practice of medical information. She received both a BS in Pharmacy and a PharmD from Rutgers and completed a Drug Information specialty residency at the Medical College of Virginia Hospital in Richmond, Virginia prior to working at the University of Utah Hospital Drug Information Service. For 25 years she was the Director of Drug Information Services at Robert Wood Johnson University Hospital and a Clinical Professor at the Ernest Mario School of Pharmacy at Rutgers.
Randy Levitt, PhD
Director, Pharmacovigilance and Medical Affairs, Paladin Labs Inc., Canada
Randy Levitt is the Director of Pharmacovigilance and Medical Affairs at Paladin. He is also the local compliance champion and works closely with the legal and compliance teams at Endo, the parent company of Paladin. He joined Paladin in 2011 as Manager, Scientific Communications and Publications after Paladin’s acquisition of Labopharm, where he had worked in the medical department since 2008. Randy completed his undergraduate and graduate degrees at McGill University, graduating with his PhD in Experimental Medicine in 2006.
Dewey McLin, PhD
Vice President, Medical Affairs, Longboard Pharmaceuticals, United States
Dewey McLin is a Medical Affairs leader with experience in CNS and rare diseases, with a career that has focused on leading the creation and development of new departments while also providing clinical support during the pre-approval period. Dewey joined the pharmaceutical industry in 2004 after completing a PhD in Neuroscience at the University of California, Irvine, where he also served as Adjunct Faculty. His professional experiences have spanned product support across all phases of development, from pre-approval to mature lifecycle management, and included both niche and multi-billion dollar products.
Daniel J. Michel, PharmD
Senior Medical Science Liaison, Neurocrine Biosciences, United States
Dan Michel has a Pharm.D. from Creighton University and a drug information residency from the University of Texas Austin. He has been in pharmaceutical industry for over 30 years, ~15 in medical information/pharmacovigilance roles and the last ~15 as a medical science liaison (MSL), in large, medium, and small companies supporting psychiatry, movement disorder neurology, epilepsy, rheumatology, and other therapeutic areas.
Christina Nixon, PhD
Senior Director, Medical and Scientific Communications, Alphanumeric, United States
As ever-questioning medical communication professional with an international reputation, I have been communicating science to children, grandmothers, business professionals, government agencies, and scientific experts for more than 15 years. My technical areas of expertise span across infectious disease, immunology, oncology, and vaccines and include content deliverables at all stages within a product's lifecycle.
Cheri Osteen, PhD
Senior Medical Director, Medical Affairs, Neuroscience, Prothena Corporation, United States
Cheri has over 20 years’ experience in the biopharmaceutical industry, primarily in Medical Affairs but also in US Commercial and organizational transformation. She has led teams across multiple therapeutic areas, all stages of drug development, and various geographic constructs (global, regional, & local). As the Head of Medical Communications at Amgen, she has led strategic communication planning, worldwide medical content creation, multichannel execution, & digital innovation. Cheri earned a PhD in Molecular, Cellular, & Integrative Physiology from the UCLA School of Medicine, focusing on neuroscience. She also holds a Masters in Physical Therapy from UCSF and worked in sports medicine for several years prior to her career in industry.
Blake Schouest, PhD
Scientific Medical Writer , Aroga Biosciences, United States
Blake is a Scientific Medical Writer at Aroga Biosciences, Inc. with experience authoring INDs, nonclinical study reports, IBs, DSURs, and FDA information requests. Blake also serves as Secretary of the San Diego Regulatory Affairs Network (SDRAN) and has completed the Regulatory Affairs Essentials Program at UC San Diego Extension. Prior to joining Aroga, Blake worked as a research scientist at Inovio Pharmaceuticals, Inc., serving as lead scientist on multiple nonclinical research programs. Blake conducted his postdoctoral training at La Jolla Institute for Immunology and holds a PhD in Biomedical Sciences from Tulane University School of Medicine.
Christina Wright, PharmD
National Director-MSLs Immunology , Sobi Pharmaceutical, United States
Helle Gawrylewski, MA
Owner, Hawkwood Consulting, LLC, United States
Helle manages Medical Affairs writing, with a staff of Regional Leads and is responsible for special projects. She joined Johnson & Johnson, former Janssen Research Foundation (JRF), in 1997 and was closely involved in developing JRF’s first electronic submission. She led the oncology writing group and assumed early development MW for global Research units. She worked in the CDISC Glossary Group and in the standards developing organizations of HL7/RCRIM/CDISC Working Group for the Protocol Representation Model. She represented PhRMA on the ICH E3 Q&A Implementation Working Group. She’s a member of the TransCelerate Transparency Leadership Team, is the CSR Redaction Sub Team Co-Lead, and has 40+ years in the pharmaceutical industry.
Mylene S. Serna, PharmD
Director, Medical Information, Springworks Therapeutics, Inc., United States
Medical Communicator, Innovator, Challenger, Collaborator Mylene S. Serna, PharmD is a dedicated Medical Affairs professional with a solid performance record in the pharmaceutical industry, with a career spanning nearly 17 years in Medical Affairs. Highlights of her career include building Medical Information capabilities, developing strategy for medical communications content, building Medical Information service solutions, and leading a medical communications team to provide strategy and oversight for various medical affairs functions. She received her Doctor of Pharmacy at Mercer University College of Pharmacy and completed a pharmacy practice residency at Mayo Clinic Jacksonville.
Natalie Batta, MD, MBA
Senior Medical Science Liaison, Alimera Sciences, United States
Natalie currently works as a Senior Medical Science Liaison at Alimera Sciences covering the West Coast. In her current role she strives to develop and maintain long-term collaborative relationships with residents, fellows, and key opinion leaders (KOL) and provide in-depth scientific, clinical, and educational support to the medical community as well as internal training. Natalie earned her Bachelor of Science in Psychobiology from UCLA, her Medical Degree from Universidad Autónoma de Guadalajara, and her MBA with an emphasis in healthcare administration from University of Redlands.
Brentt Brown, MPA
Vice President, Growth and Innovation, Mursion, United States
Brentt has dedicated his entire career to the field of education and professional learning. After a brief stint teaching, he spent over a decade conducting economic research to help spur investment in early childhood education. This led to multiple state funded universal pre-K programs. He also worked at a coaching organization focussed on helping K12 districts manage change. More recently I have transitioned to the educational technology and virtual reality sector. For eight years I have led growth and innovation for Mursion, the leading XR platform for practicing difficult conversations. I am responsible for supporting growth in our new markets, like healthcare and the public sector, and I manage strategic alliances for Mursion.
Director, Regulatory Affairs Advertising & Promotion, Alkermes, United States
Allyson Chambers currently serves as Director, Regulatory Affairs for Alkermes, Inc, a global biopharmaceutical company. She provides strategic regulatory guidance in the review and approval of advertising, promotional, educational and other materials for FDA-regulated products. With over 20 years of industry experience, Allyson has served similar roles in other companies, contributing to successful DTC advertising, corporate communications and social media campaigns for various brands.
Sheryl Flores, PhD, MBA
Director, Vaccines Medical Writing Lead, Merck & Co., Inc., United States
Sheryl Flores is a Director and TA Lead of Vaccines Medical Writing at Merck near Philadelphia, PA. She has 18+ years of pharmaceutical industry experience, ranging from designing late stage clinical programs to leading global regulatory submissions. Sheryl focuses on building high performing teams by cultivating cross-functional relationships and providing opportunities to develop medical writer talent in support of clinical programs and worldwide regulatory dossiers. With this focus, she leads teams through strategic discussions while leveraging her passion for growth and development, to maximize each team members’ ability to prepare clear, effective, and high-quality clinical and regulatory documentation.
Stacey Fung, PharmD
Head, Global Medical Information, Gilead Sciences, United States
Stacey Fung, PharmD is the Head of Global Medical Information at Gilead Sciences. Prior to joining Gilead, she held positions in the Medical Affairs departments of Genentech, Chiron Therapeutics and Protein Design Labs and has practiced in hospital and retail pharmacy settings. She is a seasoned presenter and has chaired meeting sessions at DIA workshops and annual meetings. She has authored several clinical, scientific, and pharmaceutical industry-focused articles. She received a BS in Biology from University of California Davis and PharmD from University of the Pacific. She received post-graduate training at the University of California San Francisco and a drug information residency at University of the Pacific.
Ezinneka Imoh, PharmD
Associate Director, Scientific Communications & Medical Education, Rare Diseases, Chiesi, United States
Ezinneka is currently the Associate Director of Scientific Communications & Medical Education at Chiesi Global Rare Diseases, where she's responsible for the execution of Medical Education, Training and Scientific Communication strategy for rare disease products, globally. In this role, she also drives medical information & communication initiatives (e.g., symposia, congress planning and content, independent medical education etc.). Previously, Ezinneka has held roles in Medical Review, Medical Information and Pharmaceutical Quality Assurance. She holds a Bachelor’s degree from the University of Texas and a Doctor of Pharmacy (PharmD) degree from Fairleigh Dickinson University.
Regina Lynn Preciado
Senior Director of Content Strategy Solutions, Content Rules Inc., United States
Regina Lynn Preciado is the Senior Director of Content Strategy Solutions at Content Rules. She leads content strategy teams to help pharma and biotech organizations adopt structured content successfully. She has 25+ years of experience in structured content strategy for pharma/biotech, med device, high tech, financial services, and manufacturing. Regina is an industry expert in structured content authoring, component content management, and content reuse and automation. She lives a dogspotting lifestyle.
Rena Rai, PharmD, RPh
Manager, Content Strategy and Innovation , The Janssen Pharmaceutical Companies of Johnson & Johnson, United States
Rena Rai is a Manager of the Content Strategy and Innovation team at Janssen. In her current role, Rena is responsible for the development and execution of differentiated content strategies for innovative and digital content for both global and omnichannel consumption across the portfolio. Rena earned her Doctor of Pharmacy at Rutgers University in 2019 after which she completed a residency in Drug Information and a post-doctoral fellowship in Medical Information & Executive Leadership.
Richard Swank, PhD
Executive Director & Head, Regional Medical Liaisons, Global Scientific Affairs, Amgen, Inc., United States
Richard Swank leads Global Field Medical at Amgen. He has spent most of his career building medical capabilities in Medical Affairs, including managing MSL teams, managing medical information call centers, and improving how medical teams execute and measure field medical performance. He has a PhD in Biochemistry and Molecular Biology and prior to joining industry completed an NIH Postdoctoral Fellowship and was a senior fellow in Medical Genetics at the University of Washington.
Amy Van Sant, PharmD, MBA
President, Medical Affairs, Inizio Engage, United States
With nearly 20 years of experience in the healthcare and pharmaceutical industry, Amy has held various roles of increasing responsibility within the areas of Medical Affairs and Regulatory. As the current head of US Medical Affairs, she is responsible for developing, communicating and driving strategy and leading the organization to success with a prioritized focus on the design and delivery of MI and MSL programs. Prior to joining Ashfield, Amy spent more than 10 years at Johnson & Johnson supporting the biopharmaceutical business in the areas of Immunology, Infectious Diseases, Vaccines, Global Public Health, Strategic Customer Group (Market Access), Established Products Group, and the Research & Development areas.
Sam Davis, PharmD
Director, Advertising and Promotion Review, Misocky Consulting Group, United States
Payal Desai, PharmD
Associate Director, Integrated Evidence Team Lead, Janssen Scientific Affairs, LLC., United States
Payal Desai earned a PharmD degree from the University of Sciences in Philadelphia. Dr. Desai worked in community practice before transitioning to a career in pharmaceutical industry. Over 20 years, Dr. Desai served at several pharmaceutical companies. In her current role at Janssen, she is the Integrated Evidence Team Lead and is responsible for generating the evidence generation plan within Medical Affairs. Previously, she was the Associate Director of Medical Information, where she was responsible for the successful launch of cardiovascular products, promotional review, and development of scientific responses. . She provides strategic medical support and participates in several cross-functional teams.
Allen Ho, PharmD
Director, MSL team lead, Alexion Pharmaceuticals, United States
Allen brings 15 years of experience in the pharmaceutical industry. After receiving a Pharm.D degree from University of the Pacific, Allen completed a postdoctoral fellowship in market research and competitive intelligence with Janssen Pharmaceuticals and Rutgers University. Currently, Allen is the Director, MSL team lead at Alexion Pharmaceuticals, the rare disease unit of Astrazeneca, where he leads the hematology and nephrology team for the west coast.
Jennifer Riggins, PharmD
Technology and Partnership Strategist, phactMI, United States
Dr. Jennifer Riggins has extensive experience in medical affairs, medical information, medical communications, and digital channels. She is the President of JSR Medical Affairs Consulting and also serves as the Partnership and Technology Strategist for phactMI, a non-profit organization that is both an industry Medical Information center of excellence and the single source of industry medical information. Dr. Riggins, a DIA Fellow, has served on the DIA Board of Directors and Advisory Council of North America among other activities. A dedicated PharmD student preceptor and former director of drug information residency and fellowship programs, Dr. Riggins earned her Doctor of Pharmacy degree from Butler University.
Elizabeth S. Miller, PharmD
Vice President, Scientific Director, Health & Wellness Partners, United States
Beth obtained her Doctor of Pharmacy from the University of Tennessee, Memphis. After graduation, she completed a residency in Family and Community Medicine at the University of Arkansas for Medical Sciences. She work in clinical out-patient care and investigational protocol writing until 2005 when she transitioned into Medical Communications. For the past 18 years, Beth worked in creating scientific content deliverables such as standard responses, slide decks, dossiers, and manuscripts. She has supported strategic publication planning, industry software implementation, and served in various leadership positions. She also holds an appointment as Assistant Clinical Professor for the University of Tennessee College of Pharmacy.
Sonica Sachdeva Batra, DrMed
Associate Vice President, Global Delivery Head, Indegene , India
I am an MD physician by training, with 20 years of experience in drug development and medical and scientific affairs. I am presently AVP and Global Head for Medical Affairs and Regulatory at a global technology enabled healthcare solutions provider. I have led many successful global Regulatory Authority engagements across the globe, for developed as well as the Rest of the World- emerging/ developing countries, enabling clinical development plans, strategies, marketing authorisations and post approval compliances for various products including biosimilars. I have a keen interest and experience in enhancing medical value add and scientific information dissemination for medicinal products, in the peri approval and post approval space.
John J. Doyle, DrPH, MPH
President of Consulting, Fortrea, United States
Dr. Doyle is an epidemiologist and health services researcher who specializes in studying the risks, benefits, and value of healthcare interventions. He has over 25 years of experience in conducting research covering specialties such as pharmacoepidemiology, health economics and outcomes research, and real-world evidence. He leads a global team of expert consultants across the product development lifecycle, helping customers navigate complex and fast-changing business and regulatory environments.
Shelby Lynn Biagi, PharmD
Clinical Site Management Team Lead, UCB Biosciences, Inc., United States
Dr. Biagi serves as Clinical Site Management Team Lead for UCB, Inc. She brings over 20 years of experience within the pharmaceutical industry. She has held many memberships and designations over the years including positions with the American Medical Writers Association and the Georgia Pharmacy Association. Dr. Biagi received her PharmD and Drug Information Residency from Mercer University.
A. Marie Oglesbee, PharmD
Associate Director, Medical Digital Strategy, UCB, Inc., United States
Marie is the Associate Director, Medical Digital Strategy at UCB, Inc. She has 15+ years of experience across the retail, hospital, & industry settings, including experience leading a cross-functional team focused on Medical Information, Medical Training & Operations, & Publications. Marie earned her PharmD degree from the University of Georgia, and B.S. degrees in Chemistry & Biology from Armstrong Atlantic State University (now Georgia Southern University). She completed a Pharmacy Practice Residency at Columbus Regional Healthcare System in Columbus, GA, & a Drug Information Residency with Solvay Pharmaceuticals (now Abbvie)/Mercer University in Atlanta, GA
Have an account?